For people living with HIV, recent years have seen striking advances in the range of
antiretroviral therapies available, our understanding of the optimal application of these …

As the HIV epidemic continues worldwide, and as the benefits of treatment become more
widespread, mortality from opportunistic infections appears to be in decline while the relative …

Immunodeficiency, whether congenital or acquired, iatrogenic (eg allograft recipients) or
infectious (eg human immunodeficiency virus (HIV)), is associated with an increased risk of …

This review highlights current interventional clinical trials for HIV-associated malignancies
(HIVAMs), with emphasis on 4 mechanistic areas: immunomodulatory therapies and gene …

Implementation of highly active antiretroviral therapy (HAART) has deeply changed the
landscape of HIVassociated malignancies. Some AIDS-defining tumors, namely Primitive …

With the availability of highly active antiretroviral therapy an increased mortality and
morbidity due to neoplastic diseases is expected in the future. As India is a large country and …

Currently, HIV infection and AIDS are still one of the most important epidemic diseases
around the world. As early in the initial stage of HIV epidemic, the high incidence of ADCs …

Since the publication of the last issue of the Hematology/Oncology Clinics of North America
on this subject in 1996, the treatment for and prognosis of patients with HIV infection has …

Because of tremendous advances in HIV care, the survival of many people living with HIV
(PLWH) now approaches that of the general population. This has led to a shift in the types of …

Cancer has been linked to HIV since the earliest days of the epidemic. The unusually
frequent occurrence of Kaposi sarcoma (KS) among men who have sex with men (MSM) in …